Skip to main content

Lara Grau Lopez

Institutions of which they are part

Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Lara Grau Lopez

Institutions of which they are part

Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

Grup consolidat

IP: José Antonio Ramos Quiroga
Collaborators: Pilar Lusilla Palacios, Natalia Calvo Piñero, Amanda Rodríguez Urrutia, Montserrat Corrales De la Cruz, Judit Cabana Dominguez, Marc Ferrer Vinardell, Gemma Nieva Rifa, Mª Dolores Braquehais Conesa, Lorena Arribas Garcia, Lara Grau Lopez, Constanza Daigre Blanco, Marta Ribases Haro, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Mireia Forner Puntonet, Laura Vilar Ribo, Francisco Collazos Sanchez, Silvia Alemany Sierra, Silvia Amoretti Guadall, Gara Arteaga Henriquez, Oscar Soto Angona, Natalia Llonga Tejedor, Maria Soler Artigas, Jorge Lugo Marin
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 60000
Reference: 2021 SGR 00840
Duration: 01/01/2022 - 31/12/2024

Psiquiatria, Salut Mental i Addiccions

IP: Miquel Casas Brugué
Collaborators: Natalia Calvo Piñero, Carlos Jacas Escarcellé, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, ROSA M BOSCH MUNSO, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez, Maria Soler Artigas
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 35200
Reference: 2017SGR1461
Duration: 01/01/2017 - 30/09/2021

Psiquiatria, Salut Mental i Addicions (GRC)

IP: Miquel Casas Brugué
Collaborators: Núria Gómez Barros, Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, ROSA M BOSCH MUNSO, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 27000
Reference: 2014 SGR 1357
Duration: 01/01/2014 - 31/12/2016

Related news

The new drug improves core symptoms of depression in just three days

This new method improves and streamlines drug development processes

Complemented with the analysis of genetic variants, the work led by Vall d'Hebron establishes the basis for using gene expression as a potential biomarker of risk of developing the disorder.

Related professionals

Pere Salamero Baró

Pere Salamero Baró

Main researcher
Read more
Rafael Rodríguez Lecoq

Rafael Rodríguez Lecoq

Main researcher
Read more
Jordi Mollet Sánchez

Jordi Mollet Sánchez

Read more
Maria Queralt Ferrer Menduiña

Maria Queralt Ferrer Menduiña

Main researcher
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.